{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:52:34Z","timestamp":1782888754481,"version":"3.54.5"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The globally prevalent herpes simplex virus 2 (HSV-2) establishes lifelong latent infections in sensory neurons and causes recurrent genital disease. However, no vaccine is available to prevent HSV-2 infection. The mRNA vaccine platform offers distinct advantages over protein-based approaches, including rapid antigen design, scalable production, and efficient intracellular expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prophylactic quadrivalent mRNA vaccine encoding full-length HSV-2 glycoprotein B (gB2), C (gC2), D (gD2), and E (gE2) was developed. Its immunogenicity and protective efficacy were evaluated in a murine intravaginal challenge model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Quadrivalent mRNA vaccine-immunized mice showed robust HSV-2-specific immune responses, including high titers of neutralizing antibodies and strong T cell responses, which persisted for at least 16 weeks. Upon viral challenge, vaccinated animals were fully protected from genital disease and exhibited significantly reduced viral copy numbers in the genital tract. Vaccination also inhibited the establishment of latent infections in the dorsal root ganglia, as evidenced by markedly lower HSV-2 DNA levels than those in mock-vaccinated controls. Comparative analysis showed no significant difference between co-formulated and admixed lipid nanoparticle formulations, indicating flexibility in vaccine manufacturing without compromising efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The quadrivalent mRNA vaccine provides strong and durable protection against both primary and latent infection, supporting its potential as a promising candidate for the prevention of genital herpes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1712691","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:29:12Z","timestamp":1764916152000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Design and immunogenicity of a quadrivalent mRNA vaccine targeting HSV-2 with comparative evaluation of co-formulated and admixed formulations"],"prefix":"10.3389","volume":"16","author":[{"given":"Youngran","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-In","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeongjun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonghyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gahyun","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahyeon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyusang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Ra","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hwan","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2024-056307","article-title":"Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses","volume":"101","author":"Harfouche","year":"2025","journal-title":"Sex Transm Infect"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(16)30362-x","article-title":"First estimates of the global and regional incidence of neonatal herpes infection","volume":"5","author":"Looker","year":"2017","journal-title":"Lancet Glob Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(17)30405-x","article-title":"Effect of hsv-2 infection on subsequent hiv acquisition: an updated systematic review and meta-analysis","volume":"17","author":"Looker","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422x-8-481","article-title":"Herpes simplex virus infects most cell types in vitro: clues to its success","volume":"8","author":"Karasneh","year":"2011","journal-title":"Virol J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2004.00389.x","article-title":"Herpes simplex virus: receptors and ligands for cell entry","volume":"6","author":"Spear","year":"2004","journal-title":"Cell Microbiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.15.85","article-title":"Cell entry mechanisms of hsv: what we have learned in recent years","volume":"10","author":"Agelidis","year":"2015","journal-title":"Future Virol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.4.331","article-title":"Recombinant glycoprotein vaccine for the prevention of genital hsv-2 infection: two randomized controlled trials","volume":"282","author":"Corey","year":"1999","journal-title":"Chiron Hsv Vaccine Study Group JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1006141","DOI":"10.1371\/journal.ppat.1006141","article-title":"An hsv-2 trivalent vaccine is immunogenic in rhesus macaques and highly efficacious in Guinea pigs","volume":"13","author":"Awasthi","year":"2017","journal-title":"PloS Pathog"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw7083","article-title":"Nucleoside-modified mrna encoding hsv-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes","volume":"4","author":"Awasthi","year":"2019","journal-title":"Sci Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00684-0","article-title":"Analyzing immune responses to varied mrna and protein vaccine sequences","volume":"8","author":"Park","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsrna contaminant from in vitro-transcribed mrna","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nm1592","article-title":"Multifunctional th1 cells define a correlate of vaccine-mediated protection against leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200402200-00003","article-title":"Tc1 effector diversity shows dissociated expression of granzyme B and interferon-gamma in hiv infection","volume":"18","author":"Kleen","year":"2004","journal-title":"Aids"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.11.6671","article-title":"Therapeutic effects of tumor-reactive type 1 and type 2 cd8+ T cell subpopulations in established pulmonary metastases","volume":"162","author":"Dobrzanski","year":"1999","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/v15071483","article-title":"A trivalent hsv-2 gc2, gd2, ge2 nucleoside-modified mrna-lnp vaccine provides outstanding protection in mice against genital and non-genital hsv-1 infection, comparable to the same antigens derived from hsv-1","volume":"15","author":"Egan","year":"2023","journal-title":"Viruses"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00849-11","article-title":"Immunization with a vaccine combining herpes simplex virus 2 (Hsv-2) glycoprotein C (Gc) and gd subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of hsv-2 DNA in Guinea pigs compared to immunization with gd alone","volume":"85","author":"Awasthi","year":"2011","journal-title":"J Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01089-15","article-title":"A dual-modality herpes simplex virus 2 vaccine for preventing genital herpes by using glycoprotein C and D subunit antigens to induce potent antibody responses and adenovirus vectors containing capsid and tegument proteins as T cell immunogens","volume":"89","author":"Awasthi","year":"2015","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41541-021-00414-4","article-title":"Sars-cov-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses","volume":"6","author":"Carmen","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.actbio.2017.01.056","article-title":"Promoting tissue regeneration by modulating the immune system","volume":"53","author":"Julier","year":"2017","journal-title":"Acta Biomater"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12241","article-title":"Neutrophil-macrophage cooperation and its impact on tissue repair","volume":"97","author":"Bouchery","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202322","article-title":"On the role of regulatory T cells during viral-induced inflammatory lesions","volume":"189","author":"Veiga-Parga","year":"2012","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101921-041206","article-title":"Il-4 and il-13: regulators and effectors of wound repair","volume":"41","author":"Allen","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.6417","article-title":"Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis","volume":"181","author":"Marques","year":"2008","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301215","article-title":"Differential T cell responses to residual viral antigen prolong cd4+ T cell contraction following the resolution of infection","volume":"191","author":"Misumi","year":"2013","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.01.015","article-title":"Residual antigen presentation after influenza virus infection affects cd8 T cell activation and migration","volume":"24","author":"Zammit","year":"2006","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202288109","article-title":"Long-lived epithelial immunity by tissue-resident memory T (Trm) cells in the absence of persisting local antigen presentation","volume":"109","author":"Mackay","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nature12110","article-title":"Immune surveillance by cd8\u03b1\u03b1+ Skin-resident T cells in human herpes virus infection","volume":"497","author":"Zhu","year":"2013","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1084\/jem.20061792","article-title":"Virus-Specific Cd8+ T Cells Accumulate near Sensory Nerve Endings in Genital Skin during Subclinical Hsv-2 Reactivation","volume":"204","author":"Zhu","year":"2007","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature10339","article-title":"Different patterns of peripheral migration by memory cd4+ and cd8+ T cells","volume":"477","author":"Gebhardt","year":"2011","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1257530","article-title":"T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory cd4 T cells","volume":"346","author":"Iijima","year":"2014","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/iai.11.3.476-480.1975","article-title":"Genital herpesvirus hominis infection in mice","volume":"11","author":"Overall","year":"1975","journal-title":"I Dev an Exp Model Infect Immun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.07203-11","article-title":"Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread","volume":"86","author":"Awasthi","year":"2012","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01130-14","article-title":"Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes","volume":"88","author":"Awasthi","year":"2014","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1172\/jci152310","article-title":"Trivalent nucleoside-modified mrna vaccine yields durable memory B cell protection against genital herpes in preclinical models","volume":"131","author":"Awasthi","year":"2021","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-9-2247","article-title":"Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread","volume":"83","author":"Cheshenko","year":"2002","journal-title":"J Gen Virol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.virol.2015.04.005","article-title":"Contribution of N-linked glycans on hsv-2 gb to cell-cell fusion and viral entry","volume":"483","author":"Luo","year":"2015","journal-title":"Virology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01700-10","article-title":"Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gd, gh\/gl, and gb","volume":"84","author":"Atanasiu","year":"2010","journal-title":"J Virol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/jci161968","article-title":"A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice","volume":"133","author":"Kuraoka","year":"2023","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"Fcgammariv: A novel fcr with distinct igg subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin G subclass activity through selective fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210692","article-title":"Recurrent infection transiently expands human tissue T cells while maintaining long-term homeostasis","volume":"220","author":"Dav\u00e9","year":"2023","journal-title":"J Exp Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2004.04.007","article-title":"Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase","volume":"6","author":"Adams","year":"2004","journal-title":"Microbes Infect"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.735643","article-title":"Tissue-resident-memory cd8(+) T cells bridge innate immune responses in neighboring epithelial cells to control human genital herpes","volume":"12","author":"Peng","year":"2021","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/vaccines10020184","article-title":"Evaluation of hsv-2 ge binding to igg-fc and application for vaccine development","volume":"10","author":"Galli","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq035","article-title":"Persistent genital herpes simplex virus-2 shedding years following the first clinical episode","volume":"203","author":"Phipps","year":"2011","journal-title":"J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700453","article-title":"Of mice, dirty mice, and men: using mice to understand human immunology","volume":"199","author":"Masopust","year":"2017","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/1748-7188-6-26","article-title":"Viennarna package 2.0","volume":"6","author":"Lorenz","year":"2011","journal-title":"Algorithms Mol Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1038\/s41598-024-52685-1","article-title":"A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of rna cargo size gradient","volume":"14","author":"Schober","year":"2024","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.083","article-title":"Of mice and not humans: how reliable are animal models for evaluation of herpes cd8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates","volume":"29","author":"Dasgupta","year":"2011","journal-title":"Vaccine"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104821","article-title":"Use of the Guinea pig model of genital herpes to evaluate vaccines and antivirals: review","volume":"180","author":"Bernstein","year":"2020","journal-title":"Antiviral Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1712691\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:29:13Z","timestamp":1764916153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1712691\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2025.1712691"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1712691","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"article-number":"1712691"}}